PharmaShots Weekly Snapshots (May 16 - 20, 2022)
Published: May 20, 2022 | Tags: Lipidor, P-III, AKP02, Psoriasis
Published: May 20, 2022 | Tags: Mustang Bio, MB-107, P-I/II Study, X-Linked Severe Combined Immunodeficiency
Published: May 20, 2022 | Tags: Calliditas, CHMP, Kinpeygo, Primary Immunoglobulin A Nephropathy
Published: May 20, 2022 | Tags: Abbott, TriClip Device, Navitor TAVI System, Tricuspid Regurgitation, Aortic Stenosis, EuroPCR, 2022
Published: May 20, 2022 | Tags: Zealand, Dasiglucagon, P-III, 17103 Trial, Congenital Hyperinsulinism
Published: May 20, 2022 | Tags: Mirati, MAA, EMA, Adagrasib, KRASG12C-Mutated, Non-Small Cell Lung Cancer
Published: May 19, 2022 | Tags: Active Biotech, Tasquinimod, US, FDA, Orphan Drug Designation, Myelofibrosis
Published: May 19, 2022 | Tags: Rocket, RP-L201, P-II Trial, Severe Leukocyte Adhesion Deficiency-I, ASGCT, 2022
Published: May 19, 2022 | Tags: IO Biotech, IO102-IO103, Keytruda, pembrolizumab, P-III, IOB-013, KN-D18 Trial, Melanoma
Published: May 19, 2022 | Tags: Axsome, AXS-05, P-II, ASCEND Study, Major Depressive Disorder
Published: May 19, 2022 | Tags: Evotec, Almirall, Novel Therapies, Skin Diseases, EVOiR&D Platform
Scilex Reports the Initiation of SP-103 in P-II Study for the Treatment of Acute Low Back Pain
Published: May 19, 2022 | Tags: Scilex, SP-103, P-II Study, Acute Low Back Pain
Published: May 18, 2022 | Tags: Teleflex, MANTA Vascular Closure Device, Health Canada, Approval, Large Bore Femoral Arterial, Site Closure
4D Pharma Presents Results of MRx-4DP0004 in P-I/II Trial for the Treatment of Asthma at ATS 2022
Published: May 18, 2022 | Tags: 4D Pharma, MRx-4DP0004, P-I/II Trial, Asthma, ATS, 2022
Published: May 18, 2022 | Tags: Idera, P-II, INTRIM 1 Trial, Tilsotolimod, IMO-2125, Melanoma
Published: May 18, 2022 | Tags: Ultragenyx, Abeona, ABO-102, UX111, Sanfilippo Syndrome Type A
Published: May 18, 2022 | Tags: Pfizer, BioNTech, EUA, Booster Dose, COVID-19, Vaccine
Published: May 18, 2022 | Tags: LifeArc, RQ Bio, AstraZeneca, Monoclonal Antibodies, SARS-CoV-2
Published: May 17, 2022 | Tags: MannKind, Zealand, Acquire, V-Go, Insulin Delivery Device, Diabetes
Published: May 17, 2022 | Tags: Evotec, Sernova, iPSC-Based, Beta Cell Replacement Therapy, Diabetes
Published: May 17, 2022 | Tags: Travere Therapeutics, US, FDA, NDA, Priority Review, Sparsentan, IgA Nephropathy
Published: May 17, 2022 | Tags: BMS, Opdivo, nivolumab, Yervoy, ipilimumab, P-III, CheckMate -901 Trial, Urothelial Carcinoma
Published: May 17, 2022 | Tags: AbbVie, Option Agreement, Cugene, CUG252, Autoimmune Diseases
Published: May 17, 2022 | Tags: Proteros, 2021, AstraZeneca, Epigenetic Therapies, Cancer
Published: May 16, 2022 | Tags: Emergent BioSolutions, Chimerix, Acquire, Tembexa, brincidofovir, Smallpox
Published: May 16, 2022 | Tags: KemPharm, Orphazyme, Acquire, Arimoclomol, Niemann-Pick Disease Type C
Published: May 16, 2022 | Tags: Sanofi, Sarclisa, isatuximab, P-III, IKEMA Trial, Relapsed Multiple Myeloma
Published: May 16, 2022 | Tags: Lilly, Mounjaro, tirzepatide, US, FDA, Approval, Type 2 Diabetes
Published: May 16, 2022 | Tags: AstraZeneca, PT027, P-III, MANDALA Trial, Albuterol, Budesonide, Asthma
Published: May 16, 2022 | Tags: Urovant Sciences, URO-902, P-IIa Study, Overactive Bladder, AUA, 2022
Related Post: PharmaShots Weekly Snapshots (May 09-13, 2022)
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.